Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Anaphylactic shock | x | ||
| Diarrhoea | x | ||
| Eosinophilia | x | ||
| Toxic epidermal necrolysis | x | ||
| Erythema multiforme | x | ||
| Rash | x | ||
| Haemorrhage | x | ||
| Hepatitis | x | ||
| Hypersensitivity | x | ||
| Hypokalaemia | x | ||
| Jaundice cholestatic | x | ||
| Leukopenia | x | ||
| Nausea | x | ||
| Pain | x | ||
| Pruritus | x | ||
| Convulsion | x | ||
| Stevens-Johnson syndrome | x | ||
| Swelling | x | ||
| Thrombocytopenia | x | ||
| Thrombophlebitis | x | ||
| Urticaria | x | ||
| Vomiting | x | ||
| Cystitis haemorrhagic | x | ||
| Induration | x | ||
| Pseudomembranous colitis | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |